US Stocks
BTAI

BioXcel Therapeutics, Inc. Common Stock

$1.60
+0.06 (+4.22%)

Volume:

176.321K ($277.73K)

Market Capitalization:

$34.99M

BioXcel Therapeutics Price Charts

BioXcel Therapeutics Price Chart11:5 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM1.601.591.591.581.571.571.56

BioXcel Therapeutics Market Segments

After Hours

+0.02(+1.25%)
Open$1.58
Close$1.60
Low$1.56
Low Change-0.02 (-1.27%)
High$1.60
High Change+0.02 (+1.27%)
Range$0.04
Volume3.044K
Dollar Volume$4.87K

Regular Trading Hours

+0.02(+0.96%)
Open$1.56
Close$1.58
Low$1.54
Low Change-0.02 (-1.28%)
High$1.60
High Change+0.04 (+2.57%)
Range$0.06
Volume171.837K
Dollar Volume$270.64K

Premarket

-0.01(-0.65%)
Open$1.55
Close$1.54
Low$1.54
Low Change-0.01 (-0.65%)
High$1.57
High Change+0.02 (+1.55%)
Range$0.03
Volume1.44K
Dollar Volume$2.22K

After Hours Yesterday

+0.00(+0.01%)
Open$1.54
Close$1.54
Low$1.54
Low Change0.00 (0.00%)
High$1.57
High Change+0.03 (+1.95%)
Range$0.03
Volume4.37K
Dollar Volume$6.73K

Regular Trading Hours Yesterday

-0.09(-5.25%)
Open$1.62
Close$1.54
Low$1.53
Low Change-0.10 (-5.86%)
High$1.64
High Change+0.02 (+1.09%)
Range$0.11
Volume218.68K
Dollar Volume$335.67K

Premarket Yesterday

+0.00(+0.00%)
Open$1.62
Close$1.62
Low$1.62
Low Change0.00 (0.00%)
High$1.70
High Change+0.08 (+4.94%)
Range$0.08
Volume6.964K
Dollar Volume$11.28K

BioXcel Therapeutics Stock Splits

There has been 1 stock split for BioXcel Therapeutics (BTAI). The reverse stock split occured on February 10, 2025 and reduced the outstanding shares at a ratio of 16:1.

DateTypeRatio
February 10, 2025Reverse16:1